Amyloid β-peptide induces cell monolayer albumin permeability, impairs glucose transport, and induces apoptosis in vascular endothelial cells

Journal of Neurochemistry

Volumn 68, Issue 5, 1997, Pages 1870-1881

  Blanc, Emmanuelle M ^a   Toborek, Michal ^a   Mark, Robert J ^a   Hennig, Bernhard ^b   Mattson, Mark P ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Alzheimer's disease; Bloodbrain barrier; Calcium homeostasis; Endonuclease inhibitor; Free radicals; Glucose transport; Hydrogen peroxide

Indexed keywords

ALBUMIN; AMYLOID BETA PROTEIN; CALCIUM; FREE RADICAL; GLUCOSE;

ALZHEIMER DISEASE; ANIMAL CELL; APOPTOSIS; ARTICLE; BLOOD BRAIN BARRIER; CALCIUM HOMEOSTASIS; CONTROLLED STUDY; ETIOLOGY; GLUCOSE TRANSPORT; NONHUMAN; PERMEABILITY; PRIORITY JOURNAL; SWINE; VASCULAR ENDOTHELIUM;

ANIMALIA; SUIDAE; SUS SCROFA;

EID: 0031004788     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1997.68051870.x     Document Type: Article

References (92)

1. Arispe N., Pollard H. B., and Rojas E. (1993) Giant multilevel cation channels formed by Alzheimer disease amyloid β-protein [AβP-(1-40)] in bilayer membranes. Proc. Natl. Acad. Sci. USA 90, 10573-10577.
2. Behl C., Davis J., Lesley R., and Schubert D. (1994) Hydrogen peroxide mediates amyloid β protein toxicity. Cell 77, 817-827.
3. Buee L., Hof P. R., Bouras C., Delacourte A., Perl D. P., Morrison J. H., and Fillit H. M. (1994) Pathological alterations of the cerebral microvasculature in Alzheimer's disease and related dementing disorders. Acta Neuropathol. (Berl.) 87, 469-480.
4. Butterfield D. A., Hensley K., Harris M., Mattson M. P., and Carney J. (1994) β-Amyloid peptide free radical fragments initiate synaptosomal lipoperoxidation in a sequence-specific fashion: implications to Alzheimer's disease. Biochem. Biophys. Res. Commun. 200, 710-715.
5. Cai X., Golde T., and Younkin S. (1993) Release of excess amyloid β protein from a mutant amyloid β protein precursor. Science 259, 514-516.
6. Castillo M. J., Scheen A. J., and Lefebvre P. J. (1995) Amylin/islet amyloid polypeptide: biochemistry, physiology, patho-physiology. Diabetes Metab. 21, 3-25.
7. Chang M., Shi M., and Forman H. J. (1992) Exogenous glutathione protects endothelial cells from menadione toxicity. Am. J. Physiol. 262, 637-643.
8. Citron M., Vigo-Pelfrey C., Teplow D. B., Miller C., Schenk D., Johnston J., Winblad B., Venizelos N., Lannfelt L., and Selkoe D. J. (1994) Excessive production of amyloid β-protein by peripheral cells of symptomatic and presymptomatic patients carrying the Swedish familial Alzheimer disease mutation. Proc. Natl. Acad. Sci. USA 91, 11993-11997.
9. Copani A., Koh J.-Y., and Cotman C. W. (1991) β-Amyloid increases neuronal susceptibility to injury by glucose deprivation. Neuroreport 2, 763-765.
10. Cornford E. M., Young D., Paxton J. W., Hyman S., Farrell C. L., and Elliott R. B. (1993) Blood-brain glucose transfer in the mouse. Neurochem. Res. 18, 591-597.
11. Davis-Salinas J., Saporito-Irwin S. M., Cotman C. W., and Van Nostrand W. E. ( 1995 ) Amyloid β-protein induces its own production in cultured degenerating cerebrovascular smooth muscle cells. J. Neurochem. 65, 931-934.
12. Deckwerth T. L. and Johnson E. M. (1993) Temporal analysis of events associated with programmed cell death (apoptosis) of sympathetic neurons deprived of nerve growth factor. J. Cell Biol. 123, 1207-1222.
13. Eckert A., Hartmann H., and Muller W. E. (1993) Beta-amyloid protein enhances the mitogen-induced calcium response in circulating human lymphocytes. FEBS Lett. 330, 49-52.
14. Eckert A., Hartmann H., Forstl H., and Muller W. E. (1994) Alterations in intracellular calcium regulation during aging and Alzheimer's disease in nonneuronal cells. Life Sci. 55, 2019-2029.
15. Fajardo L. F. (1989) The complexity of endothelial cells. Am. J. Clin. Pathol. 92, 241-250.
16. Forloni G., Chiesa R., Smiroldo S., Verga L., Salmona M., Tagliavim F., and Angeretti N. (1993) Apoptosis mediated neurotoxicity induced by chronic application of beta amyloid fragment 25-35. Neuroreport 4, 523-526.
17. Frackowiak J., Zoltowska A., and Wisniewski H. M. (1994) Non-fibrillar beta-amyloid protein is associated with smooth muscle cells of vessel walls in Alzheimer disease. J. Neuropathol. Exp. Neurol. 53, 637-645.
18. Furukawa K., Abe Y., and Akaike N. (1994) Amyloid β protein-induced irreversible current in rat cortical neurones. Neuroreport 5, 2016-2018.
19. Games D., Adams D., Alessandrini R., Barbour R., Berthelette P., Blackwell C., Carr T., Clemens J., Donaldson T., Gillespie F., Guido T., Hagopian S., Johnson-Wood K., Khan K., Lee M., Leibowitz E., McConlogue S., Montoya-Zavala M., Mucke L., Paganini L., Penniman E., Power M., Schenk D., Seubert P., Snyder B., Soriano F., Tan H., Vitale J., Wadsworth S., Wolozin B., and Zhao J. (1995) Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein. Nature 373, 523-527.
20. Ghiso J., Wisniewski T., and Frangione B. (1994) Unifying features of systemic and cerebral amyloidosis. Mol. Neurobiol. 8, 49-64.
21. Goodman Y. and Mattson M. P. (1994) Secreted forms of β-amyloid precursor protein protect hippocampal neurons against amyloid β-peptide-induced oxidative injury. Exp. Neurol. 128, 1-12.
22. Goodman Y. and Mattson M. P. (1996) Ceramide protects hippocampal neurons against excitotoxic and oxidative insults, and amyloid β-peptide toxicity. J. Neurochem. 66, 869-872.
23. Goodman Y., Steiner M. R., Steiner S. M., and Mattson M. P. (1994) Nordihydroguaiaretic acid protects hippocampal neurons against amyloid β-peptide toxicity, and attenuates free radical and calcium accumulation. Brain Res. 654, 171-176.
24. Gunnersen D. and Haley B. (1992) Detection of glutamine synthetase in the cerebrospinal fluid of Alzheimer diseased patients: a potential diagnostic biochemical marker. Proc. Natl. Acad. Sci. USA 89, 11949-11953.
25. Guo Q., Sopher B. L., Pham D. G., Robinson N., Martin G. M., and Mattson M. P. (1996) Alzheimer's PS-1 mutation perturbs calcium homeostasis and sensitizes PC12 cells to death induced by amyloid β-peptide. Neuroreport 8, 378-383.
26. Hemmila J. M. and Drewes L. R. (1993) Glucose transporter (GLUT1) expression by canine brain microvessel endothelial cells in culture: an immunocytochemical study. Adv. Exp. Med. Biol. 331, 13-18.
27. Hennig B., Shasby D. M., Fulton A. B., and Spector A. A. (1984) Exposure to free fatty acid increases the transfer of albumin across cultured endothelial monolayers. Arteriosclerosis 4, 489-497.
28. Hensley K., Carney J. M., Mattson M. P., Aksenova M., Harris M., Wu J. F., Floyd R., and Butterfield D. A. (1994) A model for β-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer's disease. Proc. Natl Acad. Scii. USA 91, 3270-3274.
29. Hixon J. E. (1991) Apolipoprotein E polymorphisms affect atherosclerosis in young males. Arteriosclerosis Thromb. 11, 1237-1244.
30. Horner H. C., Packan D. R., and Sapolsky R. M. (1990) Glucocorticoids inhibit glucose transport in cultured hippocampal neurons and glia. Neuroendocrinology 52, 57-64.
31. Horwood N. and Davies D. C. (1994) Immunolabelling of hippocampal microvessel glucose transporter protein is reduced in Alzheimer's disease. Virchows Arch. 425, 69-72.
32. Hoyer S. (1993) Abnormalities in brain glucose utilization and its impact on cellular and molecular mechanisms in sporadic dementia of Alzheimer type. Ann. NY Acad. Sci. 695, 77-80.
33. Kaiser N., Sasson S., Feener E. P., Boukobza-Vardi N., Higashi S., Moller D. E., Davidheiser S., Przybylski R. J., and King G. L. (1993) Differential regulation of glucose transport and transporters by glucose in vascular endothelial and smooth muscle cells. Diabetes 42, 80-89.
34. Kalaria R. N. and Grahovac I. (1990) Serum amyloid P immunoreactivity in hippocampal tangles, plaques and vessels: implications for leakage across the blood-brain barrier in Alzheimer's disease. Brain Res. 516, 349-353.
35. Kalaria R. N. and Hedera P. (1995) Differential degeneration of the cerebral microvasculature in Alzheimer's disease. Neuroreport 6, 477-480.
36. Kawai M., Kalaria R. N., Cras P., Siedlak S. L., Velasco M. E., Shelton E. R., Chan H. W., Greenberg B. D., and Perry G. (1993) Degeneration of vascular muscle cells in cerebral amyloid angiopathy of Alzheimer disease. Brain Res. 623, 142-146.
37. Kennedy A. M., Frackowiak R. S., Newman S. K., Bloomfield P. M., Seaward J., Roques P., Lewington G., Cunningham V. J., and Rossor M. N. (1995) Deficits in cerebral glucose metabolism demonstrated by positron emission tomography in individuals at risk of familial Alzheimer's disease. Neurosci. Lett. 186, 17-20.
38. Koh J., Yang L. L., and Cotman C. W. (1990) Beta-amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage. Brain Res. 553, 315-320.
39. Lansbury P. T., Costa P. R., Griffiths J. M., Simon E. J., Auger M., Halverson K. J., Kocisko D. A., Hendsch Z. S., Ashburn T. T., Spencer R. G. S., Tidor B., and Griffin R. G. (1995) Structural model for the β amyloid fibril: interstrand alignment of an antiparallel β sheet comprising a C-terminal peptide. Nat. Struct. Biol. 2, 990-997.
40. Lemere C. A., Lopera F., Kosik K. S., Lendon C. L., Ossa J., Saido T. C., Yamaguchi H., Ruiz A., Martinez A., Madrigal L., Hincapie L., Arango J. C., Anthony D. C., Koo E. H., Goate A. M., Selkoe D. J., and Arango V. J. C. (1996) The E280A presenilin 1 Alzheimer mutation produces increased Aβ42 deposition and severe cerebellar pathology. Nat. Med. 2, 1146-1150.
41. Levy-Lahad E., Wasco W., Poorkaj P., Romano D. M., Oshima J., Pettingell W. H., Yu C. E., Jondro P. D., Schmidt S. D., and Wang K. (1995) Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 269, 973-977.
42. Loo D. T., Copani A., Pike C. J., Whittemore E. R., Walencewicz A. J., and Cotman C. W. (1993) Apoptosis is induced by beta-amyloid in cultured central nervous system neurons. Proc. Natl. Acad. Sci. USA 90, 7951-7955.
43. Lorenzo A. and Yankner B. A. (1996) Amyloid fibril toxicity in Alzheimer's disease and diabetes. Ann. NY Acad. Sci. 777, 89-95.
44. Maness L. M., Banks W. A., Podlisny M. B., Selkoe D. J., and Kastin A. J. (1994) Passage of human amyloid β-protein 1-40 across the murine blood-brain barrier. Life Sci. 55, 1643-1650.
45. 2+ homeostasis and cell death. J. Neurosci. 15, 6239-6249.
46. Mark R. J., Lovell M. A., Markesbery W. R., Uchida K., and Mattson M. P. (1997a) A role for 4-hydroxynonenal, an aldehydic product of lipid peroxidation, in disruption of ion homeostasis and neuronal death induced by amyloid β-peptide. J. Neurochem. 68, 255-264.
47. Mark R. J., Pang Z., Geddes J. W., and Mattson M. P. (1997b) Amyloid β-peptide impairs glucose uptake in hippocampal and cortical neurons: involvement of membrane lipid peroxidation. J. Neurosci. 17, 1046-1054.
48. Mattila K. M., Pirttila T., Blennow K., Wallin A., Viitanen M., and Frey H. (1994) Altered blood-brain-barrier function in Alzheimer's disease? Acta Neurol. Scand. 89, 192-198.
49. Mattson M. P. (1996) Human fetal brain cell culture, in Methods in Molecular Medicine: Human Cell Culture Protocols (Jones G. E., ed), pp. 53-62. Humana Press, Totowa, New Jersey.
50. Mattson M. P. and Goodman Y. (1995) Different amyloidogenic peptides share a similar mechanism of neurotoxicity involving reactive oxygen species and calcium. Brain Res. 676, 219-224.
51. Mattson M. P., Cheng B., Davis D., Bryant K., Lieberburg I., and Rydel R. E. (1992) β-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J. Neurosci. 12, 376-389.
52. Mattson M. P., Tomaselli K., and Rydel R. E. (1993a) Calcium-destabilizing and neurodegenerative effects of aggregated β-amyloid peptide are attenuated by basic FGF. Brain Res. 621, 35-49.
53. Mattson M. P., Barger S. W., Cheng B., Lieberburg I., Smith-Swintosky V. L., and Rydel R. E. (1993b) β-Amyloid precursor protein metabolites and loss of neuronal calcium homeostasis in Alzheimer's disease. Trends Neurosci. 16, 409-415.
54. Mattson M. P., Barger S. W., Begley J. G., and Mark R. J. (1995) Calcium, free radicals, and excitotoxic neuronal death in primary cell culture. Methods Cell Biol. 46, 187-216.
55. Mattson M. P., Furukawa K., Bruce A. J., Mark R. J., and Blanc E. M. (1996) Calcium homeostasis and free radical metabolism as convergence points in the pathophysiology of dementia, in Molecular Mechanisms of Dementia (Wasco W. and Tanzi R., eds), pp. 103-143.
56. May P. C., Boggs L. N., and Fuson K. S. (1993) Neurotoxicity of human amylin in rat primary hippocampal cultures: similarity to Alzheimer's disease amyloid-β neurotoxicity. J. Neurochem. 61, 2330-2333.
57. Mecocci P., Parnetti L., Romano G., Scarelli A., Chionne F., Cecchetti R., Polidori M. C., Palumbo B., Cherubini A., and Senin U. (1995) Serum anti-GFAP and anti-S100 autoantibodies in brain aging, Alzheimer's disease and vascular dementia. J. Neuroimmunol. 57, 165-170.
58. Mueckler M. (1994) Facilitative glucose transporters. Eur. J. Biochem. 219, 713-725.
59. Mullan M. and Crawford F. (1993) Genetic and molecular advances in Alzheimer's disease. Trends Neurosci. 16, 398-403.
60. Perlmutter L. S. (1994) Microvascular pathology and vascular basement membrane components in Alzheimer's disease. Mol. Neurobiol. 9, 33-40.
61. Pettegrew J. W., Panchalingam K., Klunk W. E., McClure R. J., and Muenz L. R. (1994) Alterations of cerebral metabolism in probable Alzheimer's disease: a preliminary study. Neurobiol. Aging 15, 117-132.
62. Pike C., Burdick D., Walencewicz A., Glabe C., and Cotman C. (1993) Neurodegeneration induced by β-amyloid peptides in vitro: the role of peptide assembly state. J. Neurosci. 13, 1676-1686.
63. Saunders A. M., Strittmatter W. J., Schmechel D., St. George-Hyslop P. H., Pericak V. M. A., Joo S. H., Rosi B. L., Gusella J. F., Crapper-MacLachlan D. R., Alberts M. J., Hulette C., Crain B., Goldgaber D., and Roses A. D. (1993) Association of apolipoprotein E allele E4 with late-onset familial and sporadic Alzheimer's disease. Neurology 43, 1467-1472.
64. Scheuener D., Eckman C., Jensen M., Song X., Citron M., Suzuki N., Bird T. D., Hardy J., Hutton M., Kukull W., Larson E., Levy-Lahad E., Vitanen M., Peskind E., Poorkaj P., Schellenberg G., Tanzi R., Wasco W., Lannfelt L., Selkoe D., and Younkin S. (1996) Secreted amyloid β-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nat. Med. 2, 864-870.
65. 68Ga]EDTA and positron emission tomography. J. Cereb. Blood Flow Metab. 7, 1-8.
66. Selkoe D. J. (1993) Physiological production of the β-amyloid protein and the mechanism of Alzheimer's disease. Trends Neurosci. 16, 403-409.
67. Shearman M. S., Hawtin S. R., and Tailor V. J. (1995) The intracellular component of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction is specifically inhibited by β-amyloid peptides. J. Neurochem. 65, 218-227.
68. Shen J., Ham R. G., and Karmiol S. (1995) Expression of adhesion molecules in cultured human pulmonary microvascular endothelial cells. Microvasc. Res. 50, 360-372.
69. Sherrington R., Rogaev E. I., Liang Y., Rogaeva E. A., Levesque G., Ikeda M., Chi H., Lin C., Li G., and Holman K. (1995) Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 375, 754-760.
70. Siflinger-Birnboim A., Schnitzer J., Lum H., Blumenstock F. A., Shen C. P., Del Vecchio P. J., and Malik A. B. (1991) Lectin binding to gp60 decreases specific albumin binding and transport in pulmonary artery endothelial monolayers. J. Cell. Physiol. 149, 575-584.
71. Simmons L. K., May P. C., Tomaselli K. J., Rydel R. E., Fuson K. S., Brigham E. F., Wright S., Lieberburg I., Becker G. W., and Brems D. N. (1994) Secondary structure of amyloid beta peptide correlates with neurotoxic activity in vitro. Mol. Pharmacol. 45, 373-379.
72. Simpson I. A., Vannucci S. J., and Maher F. (1994a) Glucose transporters in mammalian brain. Biochem. Soc. Trans. 22, 671-675.
73. Simpson I. A., Chundu K. R., Davies-Hill T., Honer W. G., and Davies P. (1994b) Decreased concentrations of GLUT1 and GLUT3 glucose transporters in the brains of patients with Alzheimer's disease. Ann. Neurol. 35, 546-551.
74. Slater A. F., Nobel C. S., and Orrenius S. (1995) The role of intracellular oxidants in apoptosis. Biochim. Biophys. Acta 1271, 59-62.
75. Sparks D. L., Scheff S. W., Hunziker J. C., Liu H., Landers T., and Gross D. R. (1994) Induction of Alzheimer-like β-amyloid in the brains of rabbits with dietary cholesterol. Exp. Neurol. 126, 88-94.
76. Spolarics Z., Pekala P. H., Bagby G. J., and Spitzer J. J. (1993) Brief endotoxemia markedly increases expression of GLUT1 glucose transporter in Kupffer, hepatic endothelial and parenchymal cells. Biochem. Biophys. Res. Commun. 193, 1211-1215.
77. 717) mutants. Science 264, 1336-1340.
78. Takashima A., Noguchi K., Sato K., Hoshino T., and Imahori K. (1993) Tau protein kinase 1 is essential for amyloid beta-protein-induced neurotoxicity. Proc. Natl. Acad. Sci. USA 90, 7789-7793.
79. Takata K., Kasahara T., Kasahara M., Ezaki O., and Hirano H. (1994) Immunolocalization of glucose transporter GLUT1 in the rat placental barrier: possible role of GLUT1 and the gap junction in the transport of glucose across the placental barrier. Cell Tissue Res. 276, 411-418.
80. Tamaoka A., Kalaria R. N., Lieberburg I., and Selkoe D. J. (1992) Identification of a stable fragment of the Alzheimer amyloid protein in cerebral vessel walls. Proc. Natl. Acad. Sci. USA 89, 1345-1349.
81. Thomas J., Linssen M., van der Vusse G. J., Hirsch B., Rosen P., Kammermeier H., and Fischer Y. (1995) Acute stimulation of glucose transport by histamine in cardiac microvascular endothelial cells. Biochim. Biophys. Acta 1268, 88-96.
82. Thomas T., Thomas G., McLendon C., Sutton T., and Mullan M. (1996) β-Amyloid-mediated vasoactivity and vascular endothelial damage. Nature 380, 168-171.
83. Toborek M., Barger S. W., Mattson M. P., McClain C. J., and Hennig B. (1995) Role of glutathione redox cycle in TNFα-mediated endothelial cell dysfunction. Atherosclerosis 117, 179-188.
84. Vinters H. V., Nishimura G. S., Secor D. L., and Pardridge W. M. (1994) Microvasculature in brain biopsy specimens from patients with Alzheimer's disease: an immunohistochemical and ultrastructural study. Ultrastruct. Pathol. 18, 333-348.
85. Weinhouse G. L., Belloni P. N., and Farber H. W. (1993) Effect of hypoxia on endothelial cell surface glycoprotein expression: modulation of glycoprotein IIIa and other specific surface glycoproteins. Exp. Cell Res. 208, 465-478.
86. 2+ channel blockers attenuate β-amyloid peptide toxicity to cortical neurons in culture. J. Neurochem. 62, 372-375.
87. Whitson J. and Appel S. H. (1995) Neurotoxicity of Aβ amyloid protein in vitro is not altered by calcium channel blockade. Neurobiol. Aging 16, 5-10.
88. Wisniewski H. M., Frackowiak J., Zoltowska A., and Kim K. S. (1994) Vascular β-amyloid in Alzheimer's disease angiopathy is produced by proliferating and degenerating smooth muscle cells. Int. J. Exp. Clin. Invest. 1, 8-16.
89. Wyllie A. H., Kerr J. F. R., and Currie A. R. (1990) Cell death: the significance of apoptosis. Int. Rev. Cytol. 68, 251-306.
90. Yankner B. A. (1996) Mechanisms of neuronal degeneration in Alzheimer's disease. Neuron 16, 921-932.
91. Yankner B. A., Duffy L. K., and Kirschner D. A. (1990) Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides. Science 250, 279-282.
92. Zhou Y., Gopalakrishnan V., and Richardson J. S. (1996) Actions of neurotoxic β-amyloid on calcium homeostasis and viability of PC12 cells are blocked by antioxidants but not by calcium channel antagonists. J. Neurochem. 67, 1419-1425.